Variable | OR | 95% CI | p-value | ICCa |
---|---|---|---|---|
Male gender | 0.62 | 0.39–1.01 | 0.07 | 0.2039 |
Age | 1.03 | 1.01–1.05 | 0.001 | 0.1871 |
Diabetes mellitus | 0.98 | 0.58–1.66 | 0.82 | 0.1989 |
Haematological malignancy | 6.02 | 2.11–17.23 | < 0.001 | 0.1918 |
Solid tumour | 1.5 | 0.78–2.89 | 0.36 | 0.2035 |
Liver disease | 1.39 | 0.5–3.83 | 0.65 | 0.2002 |
Charlson index | 1.21 | 1.11–1.33 | 0.001 | 0.1723 |
Organ transplant | 0.61 | 0.2–1.87 | 0.08 | 0.1965 |
Immunosuppressive therapy | 0.7 | 0.28–1.74 | 0.40 | 0.1962 |
Corticosteroid therapy | 1.09 | 0.45–2.65 | 0.21 | 0.1964 |
Bedridden functional capacity | 3.13 | 1.83–5.37 | < 0.001 | 0.1683 |
Chronic renal impairment | 1.16 | 0.67–2.03 | 0.23 | 0.1817 |
UTI within 1 year | 0.77 | 0.42–1.41 | 0.11 | 0.1878 |
Antibiotic within 30 days | 0.63 | 0.32–1.23 | 0.09 | 0.1869 |
Acquisition of cUTI in a medical care facility | 2.42 | 1.41–4.15 | 0.001 | 0.1677 |
Urinary retention | 0.75 | 0.39–1.44 | 0.78 | 0.2149 |
Neurogenic bladder | 1.51 | 0.6–3.79 | 0.39 | 0.2001 |
Obstructive uropathy | 0.46 | 0.23–0.91 | 0.05 | 0.1905 |
Severe sepsis/ septic shock | 11.7 | 6.18–22.14 | < 0.001 | 0.3077 |
Polymicrobial infection | 1.16 | 0.63–2.15 | 0.28 | 0.1947 |
MDR-GNB | 1.13 | 0.66–1.93 | 0.69 | 0.1887 |
Urgent admission | 1.15 | 0.55–2.39 | 0.92 | 0.2006 |
Admission reason: UTI | 0.28 | 0.16–0.5 | < 0.001 | 0.1683 |
Admission from a medical care facility | 2.49 | 1.47–4.19 | 0.001 | 0.2014 |
Escherichia coli | 0.67 | 0.42–1.1 | 0.09 | 0.1946 |
Klebsiella pneumoniae | 1.05 | 0.56–1.96 | 0.95 | 0.1989 |
Pseudomonas aeruginosa | 0.7 | 0.31–1.58 | 0.41 | 0.1998 |
Enterococcus | 0.9 | 0.38–2.15 | 0.91 | 0.1999 |
Proteus mirabilis | 1.58 | 0.75–3.32 | 0.13 | 0.1947 |
Urinary catheter as infection source | 2.56 | 1.52–4.32 | < 0.001 | 0.1471 |